Company Profiles

driven by the PitchBook Platform

Kosmos Biotherapeutics

2010 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$319M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of a preclinical-stage bio-pharmaceutical platform intended to offer astrobiological therapeutics. The company's preclinical-stage biopharmaceutical platform focuses on the treatment of post-evolutionary disease in zero-gravity celestial settings.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
Cambridge, MA
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kosmos Biotherapeutics’s full profile, request a free trial.

Kosmos Biotherapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 04-Jan-2010 $319M 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Kosmos Biotherapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Apple Ventures Other Minority 000 0000 000000 0
Clairvoyant Capital Venture Capital Minority 000 0000 000000 0
Crystal Ball Ventures Venture Capital Minority 000 0000 000000 0
NASA Bioventures Other Minority 000 0000 000000 0
Omniscient Venture Partners Other Minority 000 0000 000000 0
Questions or concerns about this profile? Reach out to website-support@pitchbook.com